Dzuveo Unión Europea - islandés - EMA (European Medicines Agency)

dzuveo

laboratoire aguettant - sufentanil salt - verkir - svæfingarlyf - dzuveo is indicated for the management of acute moderate to severe pain in adult patients.

Nyxthracis (previously Obiltoxaximab SFL) Unión Europea - islandés - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - Ónæmiskerfið sera og mótefni, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Lamisil Krem 10 mg/g Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

lamisil krem 10 mg/g

karo healthcare ab - terbinafinum hýdróklóríð - krem - 10 mg/g

Metylfenidat Actavis Forðatafla 18 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

metylfenidat actavis forðatafla 18 mg

actavis group ptc ehf. - methylphenidatum hýdróklóríð - forðatafla - 18 mg

Terbinafin Actavis Tafla 250 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

terbinafin actavis tafla 250 mg

actavis group ptc ehf. - terbinafinum hýdróklóríð - tafla - 250 mg

Bactroban Smyrsli 20 mg/g Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

bactroban smyrsli 20 mg/g

glaxosmithkline pharma a/s - mupirocinum inn - smyrsli - 20 mg/g

Bactroban Nasal Nefsmyrsli 20 mg/g Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

bactroban nasal nefsmyrsli 20 mg/g

glaxosmithkline pharma a/s - mupirocinum kalsíum - nefsmyrsli - 20 mg/g